GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (XSWX:SKAN) » Definitions » Current Deferred Revenue

SKAN Group AG (XSWX:SKAN) Current Deferred Revenue : CHF0.0 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

SKAN Group AG's current deferred revenue for the quarter that ended in Dec. 2023 was CHF0.0 Mil.

SKAN Group AG Current Deferred Revenue Historical Data

The historical data trend for SKAN Group AG's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Current Deferred Revenue Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
- - - -

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial - - - - -

SKAN Group AG Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SKAN Group AG (XSWX:SKAN) Business Description

Traded in Other Exchanges
Address
Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG (XSWX:SKAN) Headlines

No Headlines